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ABSTRA CT
OBJECTIVE: The objective of this systematic review is to verify whether or not
Melatonin has a significantly positive effect on nigbt -shift workers' overall recovery,
mcx.xl. tiredness, alertness, attention. and sleep quality.
STUDY DESIGN: This study evaluates the data proven by three English primary studies
dated 1998,2000. and 2005.
DATA SOURCES: Randomized. double blind. placeb<:K:ontrolled trials which evaluates
the effect of Melatonin vs placebo pill on a group of night-sbift workers.
OU TCOMES MEASURED: The outcomes that are measured in these randomiled
controlled trials include: improvement of sleep quality, dUI'~tion of tiredness, sleep
latency. and general state during daytime hours. Profile of Mcx.xI States Questionnaire is a
measurement medium that is used in all three studies. This medium contains 65
adjectives. which are rated on a 5 IX'int scale. Other mediums that are used throughout
the three studies are Visual Analog Scale, neurophysiologic testing. Actinigrnph 1000,
StandfOrd Sleepiness Scale, The Connors Continuous Performance Test J.
RESULTS: All of the data from each of the studies illustrated that there wa.> not a
significant difference noted between the experimental groups and the control groups.
CONCLUSION: The results from the trials included in this review verified that
Melatonin does not have a sign ificantly IX'sitive effect on night -shift "!orkers' recovery,
mcx.xl, tiredness. alertness. attention, and sleep quality.
KEY WORDS: "Night-Shift Worker", "Melatonin Effects"

Zach~riah.

Melatonin and Night·Shift Workers I

introduction
Melatonin is widely knov,,," for its sleep promoting charactcristics: howcvcr, its cfficacy
in promoting quality sleep has rare ly been studied.' One m~in population that may benefit from
the slcep promoting qualities of Mclatonin is night shift workers who desire bener sleep after a
night of work. Nearly 25% of workers in the US panicipate in shift work. The majority of these
workers complain of exee,silt slcepine,;s throughout the day at the worksite and lack of sleep at
homc.~ However, the c:< a<:t pathological mechanism of this is unknown. Melatonin is a naturally

occurring hormone produced in the body that normalizes the sleep·wake cyele.1.l When an
e:<ogenous source of this hormone is introduced, in addition to the normal levels that are present.
it may funher promote better sleep habits. U This paper evaluates three randomized controlled
trials comparing the effect of Melatonin on improving sleep quaEt y. duration of tiredness, sleep
latency. and general mood state during daytime compared 10 a placebo pill . If proven to be
beneficial in this population, Melatonin could si gnificantly improve Ihei r lifestyle and result in a
beller performance during their next shift.
This substance. if provcn to be helpful and effective. could make a major differencc in
nearly all Americans.1 )" Majority of Americans use unhealthy options to fuel lhei r energy.
According to Consumer Repons. nearly 500 million dollars is spent yearly on energy drinks
alone. l Melatonin cou ld be a healthy and cost-effective alternative to this unhealthy addiction to
caffeinated beverages. Many Americans who work the night shift suffer from drowsincss.
trouble readjusti ng to their normal sleep· wake cycle. change in mood. and lack of alenness.
Thcre are numerous medical conditions such as Depression. Hypcnension. and Coronary Anery
Disease that may be caused by a lad of sleep.'·J.· Howcver. Ihe cxact pathological mechanism of
this relationship is unknown. Thc majority of individuals treat their lack of sleep with lifestyle
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modifications , over the counter methods. and prescription medications. These methods only treat
the symptom of fatigue. whereas. Melatonin essentially treats the problem and promotes better
sleep which directly provides wakefulness. Lifestyle modifications inelude exercise and cold
shower. Over the counter methods inelude energy drinks (Monster. Red Bull. etc.),
coffee/espresso shots. and caffeine pills. Provigil and Nuvigil are examples of pres.:ription
methods. Many times the alternative methods mentioned above are used to substitute for sleep.
and the majority of them are unhealthy . They often allow energy for an allotted time and almost
always lead to a "cr.I,h", eventually leaving individuals feeling e,'en drowsier. Melaton in,
however, is a healthy alternative to caffeine sources. It promotes healthy sleep habits and allows
individuals to feel rejuvenated continuously. I.H
Objective
The objective of this systematic review is to determine whether or not "Does Melatonin
have a significantly positive effect on night shift workers ' overall recovery. mood. tiredness.
alenness. and sleep quality?" My hypothe,i> is that Melatonin will be effective for overall
recovery. mood, tiredness. alennes" and sleep quality .
Methods
Several methods were used in the selection of these studies. The criteria for the selcction
of the studies melude; popu lation. interventions, comparisons. outcomes. and the desired type of
study. The population criteria consist of males and females between the age of twenty-eight and
fony-five who work night shift. I.J.4 Interventions that were used in the studies were Melatonin
tablets at variable dosages. This Melatonin tablet had to be compared to a visually identical
placebo pill in all the studies. Outcomes that were measured in all of the selected studies had to
inelude: overall recovery, mood, tiredness, alenne:is. and sleep quality. All of the studies had to
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randomi~ed.

double blind. placebo controlled, crossover trials comparing dosages of

Melatonin vs placebo and its effect on night shift workers,l.l.4 To altain the data sources. "night
shift workers" and "melatonin effects" were the keyv.'ords used in the search box. All studies hud
to be written in English and had to be published in peer-reviewed medical journals,I.).• The
research was perfonned using Mcdhne and OVlO dutabascs through the Cochrane medical
database. All anicles were selected based on the importance of outcomes to the patient
(POEMS ), Inclusion criteria included any studies that were nmdomized. control led. prospective.
considered POEMS. and published after 1996. Exclusion crileria included any study that
evaluated patients under the age of 18 or those who were not a night shift worker. I.). The
statistical medians u>ed to report the outcomes included: VAS global assessment of rttovery.
Fischer's exact test, paired T test. Wilcoxon signed nlnk test. SSS and TMB measurement.
Conners Continuous Perfonnanee Test, p-values. confidence intervals. tJ.4 Table I outlines all
the major aspects of all three randomized control trials that were evaluated . All three of the trials
contained on ly continuous data that could not be con"ened to dichotomous data. All articles had
varying dosages of Melatonin. however, they all yielded similar end results,l.l·~
Outcomes Measured
The outcomes measured in all three ReTs were variables that were re levant to the
patient such as: overall recovery. mood. tiredness. alertness. and sleep quality, 1.14 All three
randomized controlled trials measured at least one of their outcomes by using the Profile of
Mood questionnaire. The POMS contains 65 adjcctives which arc all rated on a 5-point scale.
The analysis of this survey allows the experimenter to obtain data about mood states such as:
tension-anxiety. depression-dejection. anger-hostility. vigor·act i vity. fatigue-inertia. and
confusion-bewildennenLI.l.4 In the Wright study. the PO:>1S were admini,tered every morning

Z:u;hnriah. Melatonin and Night _Shift Workcrs 4
Table I: Rcsults of Demographics of Included Studic~' ''''''
STUDY

TYPE

Wright.
1998 ( I)

Doublc blind
placebo
controlled

1/ PTS

(~G~)
YRS

"

32 - 45

19

28.2

"

211.6 ±
1.9 years

RCT
crosso,'cr trial

Jackovi'h
2(0) (2 )

Double blind
placebo
COntrolll.'tl

RCT
crosso ver trinl

C;lvallo,
2005 (3)

Double blind
placebo
controlled
ReI'
crossover trial

INCLUSION
CR ITERIA
All faculty
members in De pt
of Emergency
Medicine at
Vanderbilt
Univcl'>ily

Any willing EM
resident who
worked t,,·o series
of at least three
consecutive night
shifts separated by
at least one "'cck
of day shifls
Being;l second
year reside nt
scheduled for 2
night floot
rowtions and being
willing to refrain
from alcoholic
liquids and
sedative drugs
during any period
of the study

EXCLUS ION CRITIERIA
Facuity who did not work
nights. pregnant or
lactating womcn. subjects
taking melatonin within 30
days of trial period. mid
subjects tak ing ,neds with
sedmi"e propenics at the
time oftllc trial
Heavyalcolml usc (>2
drink.,Jday). extrcme
caffeine use (>6
eaffeinated drinks/day).
opioid or bcnzodiazepine
use. rest less leg syndrome.
or periodic limb movement
d isorder.
Presence of infant- or
todd lers in the household.
chronic illnc.>s. pregnancy,
prescHt or past depre, .• ion.
usc: of scdati ve or hypnOlic
drugs during 2 week s
preceding each period of
the study, usc of
exogenous melaton in. and
usc of light treatment
deviccs

WID

,

0

0

INTE RVENT IONS
Melatonin 5mg or placebo for 3
coosecuth'e nights aftcr night shift
duty with crosso"er to the opposite
agent after a subsequent block of
night shifts

Subjects were mndomized to
receive either melatonin I mg or
placebo, 30 to 60 minutes prior to
their daytime sleep session, for 3
consecutive days after each night
,hift. Cross over to the other agent
occurred during thcir subsequent
niltht shifts.
P~r1ieipants lOok mclutonin 3mg or
u placebo befure bedtime in the
'Horning afler night shift;
complctl.'tl a sleep diary and
udvcrM: effects questionnaire daily;
:IIId completed the profile of mood
~tatc:s and the Conners continuous
pc:rfonnance Test 3 limes in each
study week to lest mood and
attention. respect ively
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on Days 1 to 4 to assess behavior and mood levels.' In the Jockovich trial. POMS was used to
mea,ure the nighttime mood and drowsiness. The POMS survey wa, administered to all
panicipants just prior 10 each night sh ift throughout the entire length of study,' In the Cavallo
trial, POMS survey was administered to the panicipants at the end of each night shift.) There
were several additional surveys used in the studies. The Wright trial measured the primary
outcomes in their study by using the Visual Analog Scale (VAS). Neuropsychological testing
was aho performed to measure the outcomes, The secondary outcomes measured in this study
were sleep quality. duration. and tiredness. ' In addition to POMS. the Jockovich trial measured
their outcomes by using the Actigraph 1000 and Stanford Sleepiness Scale." The Cavallo trial
measured their outcomes by u,ing The Connors Continuous Performance Test 3 also_
Re,uits
The Wright study was composed of 12 male and 3 female emergency physicians whose
average age was 38.6. Some exclusion criteria for this study in panicular were women who were
pregnant or lactating. anyone who has taken Melatonin within 30 days before the trial is initiated.
and anyone who was taking a medication that had .cdative effeclS. ' The data from all three RCTs
was broken down into two subsets: e xperimental group. which included those taking Melatonin 5
mg and the control group which included tho>c taking the placebo pil1. '·)" Table 2 illustrates the
relationship between Melatonin and placebo and their effect on sleep quality and latency in the
Wright study, Eight of the physic ians were given placebo treatment initially. while the remaining
7 were given Melatonin 5 mg_'

to this study all patients ",ere presented as an intention to treat

(m) analysis. The effects of Melatonin vs placebo were measured by four as]JC<:ts of sleep

which included: sleep latency. hours of sleep per night. night awakenings. and early awakenings.
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On night I. the percentage of early awakenings was equal between the experimental group and
the control group. Howcver. on the second and th ird ni ght the control group had more ea rl y
awakenings. For the remaining three variables. the calculated measures were similar between thc
experimental group and the control group for all three nights .' All of the calculated dma proved
to show an insignificant difference. In addition to these four factors. a global <lSr.c:ssment of
recovery VAS was performed on the morning of the fourth day and revealed the Melatonin
group recovery >cores to be 60.5 ± 16.9 vs placebo scores which were 58.9 ± 14.5. The mean
improvement was 1.6 and indicated a Cl of 95 %. 1be p-value for thi, study mea,ured to be
0.29. 1 The p-value. being less than 0.05. showed a decreased relationship and statistical
irrelevance between the Melatonin therapy and the control therapy. POMS was also administered
to the patients and then evaluated. This survey showed Ihat there waS a significant difference in
scores in relation to the number of days. This indicated that as the days progressed. the
participants saw a ]XIsitive change in the effect of Melatonin. However. this considerable
difference was common among the placebo patients as ,,·ell. ' For this reason. it can not be
concluded that Melatonin was superior to placebo. As the days progressed from day 1 to day 4.
the t value for PO MS went from 42.5 to 40 for both group,. The p-values for both treatment arms
were 0.01 which proves that there i, a ]XIsi ti ve correlation. If this p-value was on ly present in
Melatonin. then the data would be substantial enough to prove that Mclmon in does playa
statistically ]XIsitivc role in its effectiveness. However. due to its presence in both group>, this
data is rendered insi gnificam. All other outcomes that wcre asscsr.c:d did not contain any re levant
differences. ' The compliance amount was not mentioned in this study. In thi s study. the NN H
was interpreted in the form of adverse events and its sewrity. The tolerability score for
Melatonin and placebo was 86.2 ± [3.9 and 82.5 ± 21.5, respectively. The scores had a p-value
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of 0.93 showing a decreased correlation between the two subjects at question. ' The most
common side effects mentioned by the partic ipants from both treatment arms were headache.
wakefulness. nightmares , and nausea. The adver,;e effects are depicted and compared to the other
RCTs in Table 6.1.3·4

Night 1

Table 2: i\1elatolJin Vs Placebo - Wri ht Stu d '
Slffp
Hours sleep Night awakenings
lalenc~I';run) ner night
Melatonin 28 ± 19
7.3±JA
2.6± IA

20%

Night 2

Placebo
18 + 15
Melatonin 2 1 + 17

7.2 + 1.2
7.4 +.9

0%

Placebo
25 +2 1
Melatonin 18 + 16
Placebo
14 + 14

7.2+1.1
7.3 + 1.0
7.1 + 1.1

Night

Ni ht 3

1.9 + 2.0
1.6 + 1.3
1.7 + 1.0
1.2+L5
1.1+1.1

Early
awakenin!!s

20%
7%

0%
7%

The Jockovich study contained nineteen residents from the University of Florida
emergency medicine department whose mean age was 28.2. The exclusion criteria included the
following: greater than two alcohol ic drinks per day. greater than six caffeinated beverages per
day. any opioid or benzodiazepine usage. restless leg syndrome. or period ic limb movement
disorder. All of these criteria would interfere in interpreting the results to a sleep study since all
of these factors playa major role in the amount and quality of sleep any individuals get. The
experimental group received I mg of

~1elatonin.

whereas. the control group consumed a visually

identical placebo pill. Profile of Mood States and Stanford Slcepiness Scale (SSSl were the two
surveys used to measure the levels of mood and sleep. respective ly. The SSS showed a baseline
score of 1.8846. The score for patients laking Melatonin was 2.2571. whereas. those taking the
placebo was 2.1282. The p-value of the SSS was o.oon. There wa, not a significant difference
between the score of the participants taking Melatonin vs plucebo. The Profile of Mood States
measured the total mood disorder ([MOl faClor and determined baseline of 5.769. TMO results
for Melatonin were 12.212 and results for placebo were 5.585. The p-value for TMD was 0.9329.
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Both of the p values exceeded 0.05 which indicated poor conelalion and proved the results to be
statistically insignificant. Thes.c

re~ults

are depicted in 'I'a bll" 3. Sleep latency and efficacy "'ere

also measured. The experimental group and the placebo group mew;ured 90.98% and 91 16%,
respectively. for the measure of sleep efficacy. For sleep latency. the data for the experimental
group was 7.59 minutes. where as. 6.80 minutes for the placebo group. The p-value for sleep
efficacy and sleep latency was 0.9318 and 0 .6739. respectil'ely.4 There was 100% complianee in
relation 10 the drug administration am! consumption. except for one incident in which the drug
was taken 15 minutes before the intended sleep s.cssion mther than the recommended 30 - 60
minutes. There was no confidence interval addressed in [he anicl .. : llle NN H was interpreted in
the form of ad,'erse evcnts and the tolerability of the c;o;perimental drug. The only

~ignifican1

adverse effects that "'ere reponed by patients were vivid dream. for one night and difficulty
.witching back

[0

a nonnal nighuime sleep intef'\·al. No othcr ad"ersc effects "'ere reponed:

The participants m this study were nOi presented in an intention·to-treat analysis. There are some
variables that might have affected the outcome of this study. Three participants did not complete
cither the SSS or PO:' IS. or both for one night shift. Thus. this night was not recorded for its
rnults. Also. it had a small sample size and lac ked standardized night schedules for all
participants. This factor made it difficult 10 compare lhe result to the greatest competency.'

TABLE 3: Co mparison of SSS and PO.\IS Res ulls betwet' n Expt"rimental group
eroup'
J ocko,'k h 2000 Stud ..
SSS
PO'\IS
1.8846
5.769
Baseline
2.2571
12. 212
Melatonin
2.1282
5.585
Placebo
P Value
.9329
60"

' "S

Con trol

The Cavallo study contained pedialric residents who were willing to ,ustain from
alcoholic beverages and sedative or hypnotic drug. during each period of the study. The effect of
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3 mg of Mciatonin on these night shift workers was measured and evaluated. The exclusion
criteria for this study were those residents with infants or toddlers in the household, those with
J

any chronic illnes5e5. pregnancies. and past or present depression. All oftllese factors have an
impact on the normal sleep wake cycle of an individual.

>0

if a negati.'e efficacy was secn, the

experimenters are unable to attribute it to the mediCation or to the environmental factors.
Participants refrained from takiog tlleir pill if it was later than 13:00 hours. This was done to
prevent any delayed effects from the Melatonin pills that may affccttheir pcrfonnance on their
neXI night shift ] In this study the individuals were not presented in an intention -to-treat analysis
manner. Three measures evaluated in this study included: sleep. anention. and mood. A sleep
diary measured each panicipant's sleep quality. The test of anention was measured and evaluated
by the Conners" Continuous Perfonnance Test. The test used to evaluate mood was the Profile of
Mood States.J When evaluating the calculation on sleep quality. no statistically significant
difference was nOied bet"'een tile two subsets. This study was separated into "morning treatment
days" and "'all days" The "'morning treatment days" accounted for the days Melatonin was laken
before 1300 hours. The "'all day" subset including lhe day following each night shift and any day
tile panicipant did nOl work the night shift. Sleep quality calculation on the morning lreatment
days soowed a score of 60.8 ± 19.6 for the placebo pill and 62.6 ± 17.7 for those laking
Melatonin. The p-value for this subset was 0.26. 3 The calcu lation and p-value proved Ihal Ihe
difference belween the placebo pill and Melatonin was insignificant The data gathered for tile
anemion survey which soowed a significant difference is illustrated in Table 4. No statistical
difference was noted belween the Iwo groups of participants for Ihe following variables: number
of commission errors. means reaction time. altentiveness. risk taking. and hit reaction time block
change.) Ho"'C\·er. for lhe variable "number of omission errors"', it "'as proven to have a
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sign ificantly lower rdle with Melatonin than the placebo pill. Melatonin was 3.0 ± 9.6 and
placebo was 4.5 ± 17.5 with a p value of 0.03. Since the p value was les, than .05. it was proven
to carry a sign ificant differen<:e .l Ta ble 5 depicts the data from the POMS survey evaluating
mood and suppons the conclusion that no statistically significant difference was noted between
the e"perimental group and [he placebo group. For example. anger-ho;;tility is one of the 6
variables measured in the POMS survey. This variable measured out to be 3.9 ± 5.9 for the
placebo and 3.9 ± 7.3 for Melatonin. with a p value of 0.S3. ) There was no confidence interval
calcu lated in this anicle , NNH was reported in terms of side effects and tolerability of the
experimental drug. The majorities of adverse effects reponed were minimally significant and had
u p--vulue of 0.09. Adverse effects included: headache. abdominal pain. nausea, vomiting,
diarrhea. excessive sleepiness. nightmares. or dinines,.l Tahle 6 further depicts the adverse
events that ....'ere noted In each of the RCTs. l.lA
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Table 6: Comnarin Ad.-erse E,-ents or all RCfs
H~ada<'"
Abdominal N.u"'~ Vomiting Diarrhea

",
J ""ko.-j<h
\\'ri

C.'-ano

,

,

;.

,

X

X

E,,,,,,,

Nightmares Vi,-id

S"' iDe"
X

X

X

X

,

,

Discu,~ion

The Wright and lockovich ,mdies mentioned Melutonin's ubi lily 10 treat jet lag and
insomnia. I.' They agree that Melutonin is used as a dietary supplement throughout the US. It has
not been reviewed by the Food and Drug Administralion. Since il is considered a dietary
supplement. it can be obtaincd over the counter ut general he~lth food stores. I . There are r.everal
limitations that were presented in
studies, the

p~rtici pants

~IJ

the RCTs. For example. in the Wright and l ockovich

were those who have intermittent night shifl work. Those who haw

worked Ihe night for long period of time are superior subjects for evalumion because there is
more of a chance that they will be able to ide nti fy the most minute changes in variables such as
alertness. sleep quality, etc. U Another limitation that present in all three RCTs was that each
study had a smal l number of subje>:ls and trials lengths were relat ively short. A larger subject
group and longer trial time yields more reliable data.l.l.4 In the Cavallo study, there was no
designated sleep time . This could be an advantage because il shows how Melatonin works in a
natural environment and not just in a controlled environment. It can also be detrimental to the
study since it can dei:rear.e the experimenter's ability to adequately compare the subjects_
Conclusion
Through ther.e studies, it can be concluded that Melatonin docs not have a significantly
positive effe>:t on night -shift workers overall recovery, mood. tiredness. alennc.>s. and sleep
quality .' ,J.4 This conclusion is veri lied in all of Ihe inclu ded rdndomiled controlled trials. All of
the studies concluded

th~t

Wakeruln<s.

Ilreams

Melawnin is not effective. thus proviog a false hypothesis.

X
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